Repression of p53-mediated transcription by MDM2: A dual mechanism

Genes and Development

Volumn 11, Issue 15, 1997, Pages 1974-1986

  Thut, Catherine J ^a   Goodrich, James A ^b   Tjian, Robert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Basal transcription; In vitro; MDM2; P53; Transcriptional inhibitor

Indexed keywords

PROTEIN P53;

ARTICLE; GENE ACTIVATION; HUMAN; PRIORITY JOURNAL; RNA TRANSLATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0030860911     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.15.1974     Document Type: Article

References (77)

1. Attardi, L.D., S.W. Lowe, J. Brugarolas, and T. Jacks. 1996. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15: 3693-3701.
2. Bargonetti, J., I. Reynisdottir, P.N. Friedman, and C. Prives. 1992. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes & Dev. 6: 1886-1898.
3. Bremner, R., B.L. Cohen, M. Sopta, P.A. Hamel, C.J. Ingles, B.L. Gallie, and R.A. Phillips. 1995. Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol. Cell. Biol. 15: 3256-3265.
4. Brown, D.R., S. Deb, R.M. Munoz, M.A. Subler, and S.P. Deb. 1993. The tumor suppressor p53 and the oncoprotein simian virus 40 T antigen bind to overlapping domains on the MDM2 protein. Mol. Cell. Biol. 13: 6849-6857.
5. Brugarolas, J., C. Chandrasekaran, J.I. Gordon, D. Beach, T. Jacks, and G. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557.
6. Bunker, C.A. and R.E. Kingston. 1994. Transcriptional repression by Drosophila and mammalian Polycomb group proteins in transfected mammalian cells. Mol. Cell. Biol. 14: 1721-1732.
7. Chasman, D.I., M.C. Leatherwood, M. Carey, and M. Ptashne. 1989. Activation of yeast polymerase II transcription by herpesvirus VP16 and GAL4 derivatives in vitro. Mol. Cell. Biol. 9: 4746-4749.
8. Chen, X., G. Farmer, H. Zhu, R. Prywes, and C. Prives. 1993. Cooperative DNA binding of p53 with TFIID (TBP): A possible mechanism for transcriptional activation. [published erratum appears in 2652.] Genes & Dev. 7: 1837-1849.
9. Chowdary, D.R., J.J. Dermody, K.K. Jha, and H.L. Ozer. 1994. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol. Cell. Biol. 14: 1997-2003.
10. de Oca Luna, R.M., D.S. Wagner, and G. Lozano. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 203-206.
11. Deng, C., P. Zhang, J.W. Harper, S. Elledge, and P. Leder. 1995. Mice lacking p21 (CIP1/WAF1) undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
12. Dignam, J.D., P.L. Martin, B.S. Shastry, and R.G. Roeder. 1983. Eukaryotic gene transcription with purified components. Methods Enzymol. 101: 582-598.
13. Dulic, V., W.K. Kaufmann, S.J. Wilson, T.D. Tlsty, E. Lees, J.W. Harper, S.J. Elledge, and S.I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1023.
14. el-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
15. Farmer, G., J. Bargonetti, H. Zhu, P. Friedman, R. Prywes, and C. Prives. 1992. Wild-type p53 activates transcription in vitro. [see comments.] Nature 358: 83-86.
16. Fields, S. and S.K. Jang. 1990. Presence of a potent transcription activation sequence in the p53 protein. Science 249: 1046-1049.
17. Finlay, C.A. 1993. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol. Cell. Biol. 13: 301-306.
18. Flemington, E.K., S.H. Speck, and W. Kaelin, Jr. 1993. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. 90: 6914-6918.
19. Flores, O., H. Lu, and D. Reinberg. 1992. Factors involved in specific transcription initiation by RNA polymerase II: Identification and characterization of factor IIH. J. Biol. Chem. 267: 2786-2793.
20. Goodrich, J.A., T. Hoey, C.J. Thut, A. Admon, and R. Tjian. 1993. Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB. Cell 75: 519-530.
21. Goodrich, J.A. and R. Tjian. 1994a. TBP-TAF complexes: Selectivity factors for eukaryotic transcription. Curr. Opin. Cell Biol. 6: 403-409.
22. _. 1994b. Transcription Factors IIE and IIH and ATP hydrolysis direct promoter clearance by RNA polymerase II. Cell 77: 145-156.
23. Haffner, R. and M. Oren. 1995. Biochemical properties and biological effects of p53. Curr. Opin. Genet. Dev. 5: 84-90.
24. Hagemeier, C., A. Cook, and T. Kouzarides. 1993. The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res. 21: 4998-5004.
25. Haines, D.S., J.E. Landers, L.J. Engle, and D.L. George. 1994. Physical and functional interaction between wild-type p53 and mdm2 proteins. Mol. Cell. Biol. 14: 1171-1178.
26. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
27. Helin, K., E. Harlow, and A. Fattaey. 1993. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13: 6501-6508.
28. Holstege, F.C.P., D. Tantin, M. Carey, P.C. van der Vliet, and H.T.M. Timmers. 1995. The requirement for the basal transcription factor IIE is determined by the helical stability of promoter DNA. EMBO J. 14: 810-819.
29. Holstege, F.C.P., P.C. van der Vliet, and H.T.M. Timmers. 1996. Opening of an RNA polymerase II promoter occurs in two distinct steps and requires the basal transcription factors IIE and IIH. EMBO J. 15: 1666-1677.
30. Hupp, T.R., D.W. Meek, C.A. Midgley, and D.P. Lane. 1992. Regulation of the specific DNA binding function of p53. Cell 71: 875-886.
31. Johnson, A.D. 1995. The price of repression. Cell 81: 655-658.
32. Jones, S.N., A.E. Roe, L.A. Donehower, and A. Bradley. 1995. Rescue of embryonic lethality in mdm2-deficient mice by absence of p53. Nature 378: 206-208.
33. Keleher, C.A., M.J. Redd, M.C. Schultz, and A.D. Johnson. 1992. Ssn6-Tup1 is a general repressor of transcription in yeast. Cell 68: 709-719.
34. Kern, S.E., J.A. Pietenpol, S. Thiagalingam, A. Seymour, K.W. Kinzler, and B. Vogelstein. 1992. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256: 827-830.
35. Ko, L.J. and C. Prives. 1996. p53: Puzzle and paradigm. Genes & Dev. 10: 1054-1072.
36. Leng, P., D.R. Brown, S. Deb, and S.P. Deb. 1995. Human oncoprotein MDM2 interacts with the TATA-binding protein in vitro and in vivo. Int. J. Oncol. 6: 251-259.
37. Levine, M. and J.L. Manley. 1989. Transcripional repression of eukaryotic promoters. Cell 59: 405-408.
38. Lillie, J.W. and M.R. Green. 1989. Transcriptional activation by the adenovirus E1a protein. Nature 338: 39-14.
39. Lillie, J., M. Green, and M.R. Green. 1986. An adenovirus E1a protein region required for transformation and transcriptional repression. Cell 46: 1043-1051.
40. Lin, J., J. Chen, B. Elenbaas, and A.J. Levine. 1994. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcription activation, binding to mdm-2, and the adenovirus 5 E1B 55-kD protein. Genes & Dev. 8: 1235-1246.
41. Liu, X., C.W. Miller, P.H. Koeffler, and A.J. Berk. 1993. The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription. Mol. Cell. Biol. 13: 3291-3300.
42. Lu, H. and A.J. Levine. 1995. Human TAFII31 protein is a transcriptional coactivator of the p53 protein. Proc. Natl. Acad. Sci. 92: 5154-5158.
43. Lu, H., L. Zawel, L. Fisher, J.-M. Egly, and D. Reinberg. 1992. Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II. Nature 358: 641-645.
44. Maxon, M., J.A. Goodrich, and R. Tjian. 1994. Transcription factor IIE binds preferentially to RNA polymerase IIa and recruits TFIIH: A model tor promoter clearance. Genes & Dev. 8: 515-524.
45. Miyashita, T. and J.C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human hax gene. Cell 80: 293-299.
46. Momand, J., G.P. Zambetti, D.C. Olson, D. George, and A.J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibts p53-mediated transactivation. Cell 69: 1237-1245.
47. Ohkuma, Y. and R.G. Roeder. 1994. Regulation of TFIIH ATPase and kinase activities by TFIIE during active initiation complex formation. Nature 368: 160-163.
48. Ohkuma, Y., S. Hashimoto, C.K. Wang, M. Horikoshi, and R.G. Roeder. 1995. Analysis of the role of TFIIE in basal transcription and TFIIH-mediated carboxy-terminal domain phosphorylation through structure-function studies of TFIIE-α. Mol. Cell. Biol. 15: 4856-4866.
49. Oliner, J.D., K.W. Kinzler, P.S. Meltzer, D.L. George, and B. Vogelstein. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83.
50. Oliner, J.D., J.A. Pietenpol, S. Thiagalingam, J. Gyuris, K.W. Kinzler, and B. Vogelstein. 1993. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362: 857-860.
51. Paroush, Z., R.L. Finley, Jr., T. Kidd, S.M. Wainwright, P.W. Ingham, R. Brent, and D. Ish-Horowicz. 1994. Groucho is required for Drosophila neurogenesis, segmentation, and sex determination and interacts directly with hairy-related bHLH proteins. Cell 79: 805-815.
52. Parvin, J.D., H.T.M. Timmers, and P.A. Sharp. 1992. Promoter specificity of basal transcription factors. Cell 68: 1135-1144.
53. Ranish, J.A., W.S. Lane, and S. Hahn. 1992. Isolation of two genes that encode subunits of the yeast transcription factor IIA. Science 255: 1127-1129.
54. Raycroft, L., H.Y. Wu, and G. Lozano. 1990. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249: 1049-1051.
55. Roy, R., L. Schaeffer, S. Humbert, W. Vermeulen, G. Weeda, and J.-M. Egly. 1994. The DNA-dependent ATPase activity associated with the class II basic transcription factor BTF2/ TFIIH. J. Biol Chem. 269: 9826-9832.
56. Saha, S., J.M. Brickman, N. Lehming, and M. Ptashne. 1993. New eukaryotic transcriptional repressors. Nature 363: 648-652.
57. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
58. Sauer, F., J.D. Fondell, Y. Ohkuma, R.G. Roeder, and H. Jäckle. 1995. Control of transcription by Krüppel through interactions with TFIIB and TFIIEβ. Nature 375: 162-164.
59. Sawadogo, M. and R. Roeder. 1985. Factors involved in specific transcription by human RNA polymerase II: Analysis by a rapid and quantitative in vitro assay. Proc. Natl. Acad. Sci. 82: 4394-4398.
60. Schaeffer, L., R. Roy, S. Humbert, V. Moncollin, W. Vermeulen, J.H.J. Hoeijmakers, P. Chambon, and J.-M. Egly. 1993. DNA repair helicase: A component of BTF2 (TFIIH) basic transcription factor. Science 260: 58-63.
61. Schneffner, M., J.M. Huibregtse, R.D. Vierstra, and P.M. Howley. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495-505.
62. Sellers, W.R., J.W. Rodgers, and W.G.J. Kaelin. 1995. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when hound to E2F sites, Proc. Natl. Acad. Sci. 92: 11544-11548.
63. Serizawa, H., R.C. Conaway, and J.W. Conaway. 1993. Multifunctional RNA polymerase II initiation fgactor delta from rat liver: Relationship between carhoxyl-terminal domain kinase, ATPase, and DNA kinase. J. Biol. Chem. 268: 17300-17308.
64. Serizawa, H., J.W. Conaway, and R.C. Conaway. 1994. An oligomeric form of the large subunit of transcription factor (TF) IIE activates phosphorylation of the RNA polymerase II carboxy-terminal domain by TFIIH. J. Biol. Chem. 269: 20750-20756.
65. Seto, E., A. Usheva, G.P. Zambetti, J. Momand, N. Horikoshi, R. Weinmann, A.J. Levine, and T. Shenk. 1992. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl. Acad. Sci. 89: 12028-12032.
66. Smith, M.L., I.-T. Chen, Q. Zhan, I. Bae, C.-Y. Chen, T.M. Gilmer, M.B. Kastan, P.M. O'Conner, and A.J.J. Fornace. 1994. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266: 1376-1380.
67. Sopta, M., Z.F. Burton, and J. Greenblatt. 1989. Structure and associated DNA-helicase activity of a general transcription initiation factor that binds to RNA polymerase II. Nature 341: 410-414.
68. Takenaka, I., F. Morin, B.R. Seizinger, and N. Kley. 1995. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem. 270: 5405-5411.
69. Thut, C.J., J.-L. Chen, R. Klemm, and R. Tjian. 1995. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science 267: 100-104.
70. Truant, R., H. Xiao, C.J. Ingles, and J. Greenblatt. 1993. Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein. J. Biol. Chem. 268: 2284-2287.
71. Unger, T., M.M. Nau, S. Segal, and J.D. Minna. 1992. p53: A transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer. EMBO J. 11: 1383-1390.
72. Wang, X.W., K. Forrester, H. Yeh, M.A. Feitelson, J.R. Gu, and C.C. Harris. 1994. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl. Acad. Sci. 91: 2230-2234.
73. Weintraub, S.J., K.N.B. Chow, R.X. Luo, S.H. Zhang, S. He, and D.C. Dean. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375: 812-815.
74. Xiao, H., A. Pearson, B. Coulombe, R. Truant, S. Zhang, J.L. Regier, S.J. Triezenberg, D. Reinberg, O. Flores, C.J. Ingles, and J. Greenblatt. 1994. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell. Biol. 14: 7013-7024.
75. Xiong, Y., G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Science 366: 701-704.
76. Yew, P.R., X. Liu, and A.J. Berk. 1994. Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes & Dev. 8: 190-202.
77. Zambetti, G.P., J. Bargonetti, D. Walker, C. Prives, and A.J. Levine. 1992. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes & Dev. 6: 1143-1152.